These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
3 files

Imidazolyl-Phenyl (IMP) Anions: A Modular Structure for Tuning Solubility and Coordinating Ability

submitted on 05.07.2019, 14:20 and posted on 08.07.2019, 13:11 by Derek Wozniak, Andrew Hicks, William A. Sabbers, Graham Dobereiner
The effect of counteranion upon a cation’s solution-phase reactivity depends on a subtle interplay of weak interactions. Although these effects are widely appreciated in synthesis and catalysis, probing and controlling anion-cation interactions remains a significant challenge. Here we report the synthesis, characterization and reactivity of the IMP anions, a family of anions with a coordinating ability that can be tuned for a given application. The anions are robust, compatible with both strongly basic and acidic media, suitable for isolation of unstable organometallic species, and effective as counteranions for homogeneous catalysis. IMP anions are prepared in two steps: deprotonation of substituted 2-phenylimidazoles with NaH, followed by addition of 2 equiv. B(C6F5)3. The anions prepared feature a range of functionality, including nitro, ester, amide, amine and alcohol groups. Based on the spectroscopic properties of [Pd(IPr)(C(O)C9H6N)] [IMP-R], the coordinating ability of [IMP-R]− ranges between BF4− and BArF4−, depending on the polarity of the R group. Gold complexes of type [L-Au-L’][IMP-R] have been isolated and characterized, resulting in the first X-ray structure of a (eta-2-diphenylacetylene)Au complex. [(tBuXPhos)Au(MeCN)][IMP-R] catalyzes [2+2] cyclization of alkenes and alkynes, as well as the hydroalkoxylation of alkynes. Unlike SbF6− and BArF4−, the [IMP-H]− and [IMP-CF3]− salts are sufficiently soluble to efficiently promote cyclizations in toluene with [(tBuXPhos)Au(MeCN)]+.


National Science Foundation (CHE-1656721)

ACS Petroleum Research Fund

Pennsylvania Department of Health (CURE)


Email Address of Submitting Author


Temple University


United States

ORCID For Submitting Author


Declaration of Conflict of Interest